Discover 1,438 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Tampa FL, Fort Myers FL, Jacksonville FL, Atlanta GA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
Location: Tampa FL, Charleston SC, Birmingham AL, Durham NC,
Sponsor: CatalYm GmbH
Sex: All
Age: 18+
Code: NCT07098988
Phase2, Recruiting
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
for
Metastatic Breast Cancer in the Liver
Location: Tampa FL, Columbus OH, Dallas TX, Cleveland OH
Sponsor: Delcath Systems Inc.
Sex: All
Age: 18+
Code: NCT06875128
Phase2, Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Tampa FL, Coral Springs FL, Nashville TN, Houston TX,
Sponsor: Prelude Therapeutics Incorporated
Sex: All
Age: 18+
Code: NCT07469891
Phase1, Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Location: Port Charlotte FL, Orlando FL, Miami FL, Durham NC,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 12+
Code: NCT04585750
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Tampa FL, Jacksonville FL, Durham NC, Nashville TN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07491445
Phase3, Recruiting
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Tampa FL, Winston-Salem NC, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06015880
Phase1, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
for
NSCLC Stage IV
Location: Tampa FL, Fort Lauderdale FL, Charleston SC, Atlanta GA,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase3, Recruiting
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
for
Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer,
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05681780
Phase1, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
for
Severe Aplastic Anemia
Location: Tampa FL, Atlanta GA, Birmingham AL, Charlotte NC,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 3 - 70+
Code: NCT06517641
Phase2, Recruiting
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
for
Chronic Myelomonocytic Leukemia,
Location: Tampa FL, Houston TX, Boston MA, Rochester MN,
Sponsor: Solu Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06950034
Phase1, Recruiting
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
for
Bacterial Conjunctivitis
Location: Largo FL, Tampa FL, Lutz FL, Palm Springs FL,
Sponsor: Baxis Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT06911424
Phase3, Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
for
Lymphoma
Location: Tampa FL, Nashville TN, Houston TX, Columbus OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT07015242
Phase2, Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Tampa FL, Miami FL, Jacksonville FL, Chapel Hill NC,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07406633
Phase2, Recruiting
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
for
Small Cell Lung Cancer
Location: Tampa FL, Memphis TN, Fairfax VA, New York NY, Zion IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07531095
Phase1, Recruiting
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT04975152
Phase1, Recruiting
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
for
Relapsed or Refractory Large B-cell Lymphoma
Location: Tampa FL, Newnan GA, Charlotte NC, Nashville TN,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT07479797
Phase3, Recruiting
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
for
Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT07357298
Phase3, Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Tampa FL, Nashville TN, Fairfax VA, St Louis MO,